EPOR and gastric cancer: EPOR overexpression in tumor tissue is associated with a poor prognosis in a variety of malignancies, including breast cancer [20-23], melanoma [24], renal cell carcinoma [25], gastric cancer [26], pediatric tumors [27], and uterine and ovarian carcinoma [28].